Fetosense
07/11/2023
CareNX Innovations Mumbai, a start-up incubated at the IIT Mumbai, has come up with an innovative on-field tested innovation to reduce infant mortality rate (IMR) by at least 52%. Its patented product “Fetosense- AI based foetal heart monitoring solution” has shown 33% early high-risk detection with government facilities in the last 2 years.
Fetosense is already installed in 500+ private hospitals, 10+ government hospitals (including GMCH Aurangabad, GMCH Udhampur, AIIMS Delhi & Nagpur and AFMC Pune etc.), tested more than 150,000+ patients and has been accepted by the National Health Mission (NHM) for project implementation plan of Maharashtra state government for FY 2022-23. Fetosense can be used by trained and qualified personnel in antepartum testing areas, in mobile vans, on field and by every government facility like Medical Colleges, District Hospitals and Primary Health Centres (PHC).
